GSK Sells $1bn Discounted Stake In Spin-Off Haleon
British drugmaker GSK on Friday sold 240 million shares in its consumer healthcare business Haleon at 335 pence per share, raising about £804 million...
Haleon First Quarter Profit Misses Analyst Expectations
Haleon, the world's biggest standalone consumer health business, has reported first-quarter profit below analyst expectations.
The most important stories from European grocery retail direct to your inbox every Thursday